Akebia Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.

About AKBA

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. 

CEO
John P. Butler
CEOJohn P. Butler
Employees
181
Employees181
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
181
Employees181

AKBA Key Statistics

Market cap
359.57M
Market cap359.57M
Price-Earnings ratio
-20.37
Price-Earnings ratio-20.37
Dividend yield
Dividend yield
Average volume
3.55M
Average volume3.55M
High today
$1.60
High today$1.60
Low today
$1.33
Low today$1.33
Open price
$1.55
Open price$1.55
Volume
6.74M
Volume6.74M
52 Week high
$4.08
52 Week high$4.08
52 Week low
$1.30
52 Week low$1.30

Stock Snapshot

As of today, Akebia Therapeutics(AKBA) shares are valued at $1.41. The company's market cap stands at 359.57M, with a P/E ratio of -20.37.

During the trading session on 2026-02-12, Akebia Therapeutics(AKBA) shares reached a daily high of $1.60 and a low of $1.33. At a current price of $1.41, the stock is +5.6% higher than the low and still -12.2% under the high.

Trading activity shows a volume of 6.74M, compared to an average daily volume of 3.55M.

Over the past 52 weeks, Akebia Therapeutics(AKBA) stock has traded between a high of $4.08 and a low of $1.30.

Over the past 52 weeks, Akebia Therapeutics(AKBA) stock has traded between a high of $4.08 and a low of $1.30.

AKBA News

TipRanks 2d
Akebia’s Praliciguat FSGS Trial Moves Forward, Adding Optionality to the Kidney Pipeline

Akebia Therapeutics (AKBA) announced an update on their ongoing clinical study. The Phase 2 study titled “A Phase 2 Randomized, Double-Blind, Placebo-Controlle...

People also own

Based on the portfolios of people who own AKBA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.